CVE-2014-6721: The Pharmaguideline (aka com.pharmaguideline) application 1.2.0 for Android does not verify X.509 certificates

Routine

MEDIUM 5.4DOWNGRADE

CVE-2014-6721 is a medium-severity flaw (CVSS 5.4) affecting pharmaguideline. Below: why it ranks where it does, which versions are affected, what to do, and the exact commands.

The Pharmaguideline (aka com.pharmaguideline) application 1.2.0 for Android does not verify X.509 certificates from SSL servers, which allows man-in-the-middle attackers to spoof servers and obtain sensitive information via a crafted certificate.

Why this priority

No elevated risk signals yet

No fix is published yet: follow the downgrade or mitigation steps.

Risk facts

CVSS score	5.4 (Medium)
EPSS exploit chance	0.7% (top 49%)
CISA exploited list	No
Weakness	CWE-310
Published	2014-09-26
Last modified	2026-06-17

Publisher (CNA): CERT/CC · Vendor: pharmaguideline

Last updated 2026-06-17 · Sources: CVE Program, NVD, CISA KEV, EPSS and vendor advisories · How we score

Am I affected?

Timeline

2014-09-26 10:55 UTCPublished CVE record published
2026-06-17 00:13 UTCUpdated Record last modified

pharmaguideline pharmaguideline DOWNGRADE

Affected: 1.2.0

Fixed in: no fixed release known

Safe to downgrade to: a release before 1.2.0

1. Check installed version

apt-cache policy pharmaguideline || rpm -q pharmaguideline || pharmaguideline --version

2. No fixed release: DOWNGRADE to a release before 1.2.0 (Debian / Ubuntu)

apt-cache madison pharmaguideline sudo apt install pharmaguideline=<VERSION_BEFORE_1.2.0> sudo apt-mark hold pharmaguideline

2. No fixed release: DOWNGRADE (RHEL / Amazon Linux / Fedora)

dnf --showduplicates list pharmaguideline sudo dnf downgrade pharmaguideline-<VERSION_BEFORE_1.2.0> sudo dnf versionlock add pharmaguideline

Downgrade risk

Downgrading can break dependent software and may reopen older bugs. Read the distro advisory first and test on a non-production host.

After downgrade

Restart the service, and keep the package held until a fixed release ships.

Verify at the official source NVD · CVE Program · Report a problem with this page
Scores and fixes here are computed automatically from those and other public sources. Confirm with the vendor advisory before changing production systems.

Quick answers

How do I fix CVE-2014-6721?

pharmaguideline: downgrade or apply the listed mitigation. Exact commands for each OS are on this page.

Is CVE-2014-6721 being exploited?

CVE-2014-6721 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.

What does CVE-2014-6721 affect?

CVE-2014-6721 affects pharmaguideline. Severity is medium (CVSS 5.4). The Pharmaguideline (aka com.pharmaguideline) application 1.2.0 for Android does not verify X.509 certificates from SSL servers, which allows man-in-the-middle attackers to spoof servers and obtain sensitive information via a crafted certif

How urgent is CVE-2014-6721?

Priority 32/100. No elevated risk signals yet.

Software pages

Android vulnerabilities

References

← Back to latest CVEs